New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...

Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

Russia’s president is said to have blamed birds or a Ukrainian drone for a Dec. 25 crash of an Azerbaijani plane. Azerbaijan says Russian air defenses were at fault. By Anton Troianovski “I ...

Peter van Agtmael for The New York Times Israelis checking news updates in Tel Aviv. Avishag Shaar-Yashuv for The New York Times Injured Palestinians at Al Ahli Arab hospital in Gaza City after ...

IPC Indice de Precios Y Cotizaciones 49,844.00 14.03 0.03% ...

It all started right here when Oprah had the aha moment: Obesity is a disease, she realized, not a failure of willpower. Below, the moment that changed the conversation around weight and shame, plus ...